These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 21709195)

  • 1. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas.
    Kandel C; Leclair F; Bou-Hanna C; Laboisse CL; Mosnier JF
    J Clin Pathol; 2014 Apr; 67(4):307-12. PubMed ID: 24218028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER3 overexpression and survival in solid tumors: a meta-analysis.
    Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
    J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
    Li G; Gu RM; Wen X; Ming XZ; Xia L; Xu XY; Zhang J; Chen HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):668-72. PubMed ID: 23888453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
    Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
    Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
    Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
    Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases.
    Roh JH; Srivastava A; Lauwers GY; An J; Jang KT; Park CK; Sohn TS; Kim S; Kim KM
    Am J Surg Pathol; 2010 Aug; 34(8):1139-46. PubMed ID: 20661012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
    Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A
    Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
    Yang J; Luo H; Li Y; Li J; Cai Z; Su X; Dai D; Du W; Chen T; Chen M
    Cell Biochem Biophys; 2012 Jan; 62(1):221-8. PubMed ID: 21927816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 status in unusual histological variants of gastric adenocarcinomas.
    Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
    J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    Cao GD; Chen K; Chen B; Xiong MM
    BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
    Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
    Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression.
    Chen PC; Yu HJ; Chang YH; Pan CC
    J Clin Pathol; 2013 Feb; 66(2):113-9. PubMed ID: 23087329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.